Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Zitzmann

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Journal of Andrology|September 5, 2003
Pharmacokinetics and degree of aromatization rather than total dose of different preparations determine the effects of testosterone: a nonhuman primate study in Macaca fascicularisGerhard F Weinbauer, Carl-Joachim Partsch, Michael Zitzmann, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|November 28, 2025
Risk-dependent decision-making for circumcision in penile corporoplasty: type-2 diabetes mellitus associated with post-surgical phimosisRon Pascal Wolf, Sabine Kliesch, Michael Zitzmann, et al.
Psychoneuroendocrinology|October 7, 2009
Aging males' symptoms in relation to the genetically determined androgen receptor CAG polymorphism, sex hormone levels and sample membershipGudrun Schneider, Kathrin Nienhaus, Jörg Gromoll, et al.
The Journal of Sexual Medicine|September 3, 2011
Sex hormone levels, genetic androgen receptor polymorphism, and anxiety in ≥50-year-old malesGudrun Schneider, Kathrin Nienhaus, Jörg Gromoll, et al.
The Journal of Urology|July 2, 2014
Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registriesAhmad Haider, Michael Zitzmann, Gheorghe Doros, et al.
Praxis|April 27, 2022
Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids UsersIngo Butzke, Samuel Iff, Michael Zitzmann, et al.
The Journal of Sexual Medicine|July 21, 2012
IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 menMichael Zitzmann, Andreas Mattern, Jens Hanisch, et al.
European Journal of Endocrinology|January 8, 2014
Restoration of fertility by gonadotropin replacement in a man with hypogonadotropic azoospermia and testicular adrenal rest tumors due to untreated simple virilizing congenital adrenal hyperplasiaJulia Rohayem, Frank Tüttelmann, Con Mallidis, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samplesGudrun Schneider, Kathrin Nienhaus, Jörg Gromoll, et al.
Archives of Gynecology and Obstetrics|February 2, 2019
Androgen receptor gene polymorphism and sexual function in midlife womenBarbara Sutter, Manuela Fehr, Conny Hartmann, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Journal of Andrology|September 5, 2003
Pharmacokinetics and degree of aromatization rather than total dose of different preparations determine the effects of testosterone: a nonhuman primate study in Macaca fascicularisGerhard F Weinbauer, Carl-Joachim Partsch, Michael Zitzmann, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|November 28, 2025
Risk-dependent decision-making for circumcision in penile corporoplasty: type-2 diabetes mellitus associated with post-surgical phimosisRon Pascal Wolf, Sabine Kliesch, Michael Zitzmann, et al.
Psychoneuroendocrinology|October 7, 2009
Aging males' symptoms in relation to the genetically determined androgen receptor CAG polymorphism, sex hormone levels and sample membershipGudrun Schneider, Kathrin Nienhaus, Jörg Gromoll, et al.
The Journal of Sexual Medicine|September 3, 2011
Sex hormone levels, genetic androgen receptor polymorphism, and anxiety in ≥50-year-old malesGudrun Schneider, Kathrin Nienhaus, Jörg Gromoll, et al.
The Journal of Urology|July 2, 2014
Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registriesAhmad Haider, Michael Zitzmann, Gheorghe Doros, et al.
Praxis|April 27, 2022
Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids UsersIngo Butzke, Samuel Iff, Michael Zitzmann, et al.
The Journal of Sexual Medicine|July 21, 2012
IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 menMichael Zitzmann, Andreas Mattern, Jens Hanisch, et al.
European Journal of Endocrinology|January 8, 2014
Restoration of fertility by gonadotropin replacement in a man with hypogonadotropic azoospermia and testicular adrenal rest tumors due to untreated simple virilizing congenital adrenal hyperplasiaJulia Rohayem, Frank Tüttelmann, Con Mallidis, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samplesGudrun Schneider, Kathrin Nienhaus, Jörg Gromoll, et al.
Archives of Gynecology and Obstetrics|February 2, 2019
Androgen receptor gene polymorphism and sexual function in midlife womenBarbara Sutter, Manuela Fehr, Conny Hartmann, et al.
Pageof 13